Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Rating) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $565.28 and traded as low as $484.36. Bio-Rad Laboratories shares last traded at $484.36, with a volume of 1,519 shares changing hands.
Analysts Set New Price Targets
Separately, TheStreet cut Bio-Rad Laboratories from a “b” rating to a “c+” rating in a research note on Thursday, April 28th.
Bio-Rad Laboratories Stock Down 2.7 %
The company has a quick ratio of 4.16, a current ratio of 5.10 and a debt-to-equity ratio of 0.12. The firm’s 50-day moving average price is $503.49 and its 200 day moving average price is $565.28. The firm has a market cap of $14.50 billion, a P/E ratio of -99.25 and a beta of 0.79.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
- Get a free copy of the StockNews.com research report on Bio-Rad Laboratories (BIO.B)
- Exxon Mobil Leads The Oil Sector: Have Both Peaked?
- Get These 3 Juicy Dividend Yields While They Last
- How Low Can DocuSign Stock Go?
- These 3 Mega Caps are Bear Market Buys
- The Top-Rated Consumer Defensive Stocks With Yield Above 3.5%
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.